Research ArticleOriginal Article
Open Access
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia
Mohammed T. Tayeb, Caroline Clark, Neva E. Haites, Linda Sharp, Graeme I. Murray and Howard L. McLeod
Saudi Medical Journal April 2004, 25 (4) 447-451;
Mohammed T. Tayeb
PO Box 1074, Makkah, Kingdom of Saudi Arabia. Tel. + 966 (2) 5270000 Ext. 4012. Fax. + 966 (2) 5270000 Ext. 7110. E-mail: [email protected]
Caroline Clark
Department of Molecular and Cell Biology, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.
Neva E. Haites
Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.
Linda Sharp
Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.
Graeme I. Murray
Department of Pathology, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom.
Howard L. McLeod
Department of Medicine, Washington University, St Louis, United States of America.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Saudi Medical Journal
Vol. 25, Issue 4
1 Apr 2004
Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia
Mohammed T. Tayeb, Caroline Clark, Neva E. Haites, Linda Sharp, Graeme I. Murray, Howard L. McLeod
Saudi Medical Journal Apr 2004, 25 (4) 447-451;
Jump to section
Related Articles
- No related articles found.